Literature DB >> 32360326

Prevalence and fatality rates of COVID-19: What are the reasons for the wide variations worldwide?

Jaffar A Al-Tawfiq1, Roberto Leonardi2, Gino Fasoli3, Daniele Rigamonti4.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32360326      PMCID: PMC7188640          DOI: 10.1016/j.tmaid.2020.101711

Source DB:  PubMed          Journal:  Travel Med Infect Dis        ISSN: 1477-8939            Impact factor:   6.211


× No keyword cloud information.
To the Editor, The emergence of the novel coronavirus disease-19 (COVID-19) in December 2019 resulted in a significant number of cases as reported by the World Health Organization (WHO) and was subsequently declared by the WHO as a pandemic on Mar 11, 2020. The review of the WHO data reveals some perplexing facts. There was a genetic variation of SARS-CoV-2, the etiologic agent of COVID-19 [1]. In addition, there were three genomic variants, termed A, B, and C, based on amino acid changes. COVID-19 variant A is the ancestral type, and both A and C types are found in significant proportions in Europe and America [2]. In the absence of a documented difference in the virulence of these COVID-19 variants, it is challenging to explain the wild differences in prevalence and mortality rates in the different countries affected by COVID-19. Differences in the diagnostic efforts, or differences in the definition or reporting cannot, in our opinion, explain the wide variation of the data. Climactic conditions have been postulated as a potential explanation for heightened transmission of COVID-19 and the occurrence of community outbreaks in countries with temperature of 5–11 °C and low humidity resembles seasonal influenza [3]. However, other factors, such as greater number of commercial or tourist travel might independently influence the spread of COVID-19. Specifically, when we examined the reported data, we were struck by the great variability of the number of confirmed cases per million. According to the available data as of April 16, 2020, the number of confirmed cases/million is 2732 in Italy, 207 in Korea, 909 in Iran, 982 in Bahrain, 3864 in Spain, 57 in China, 68 in Japan, and 168 in the Kingdom of Saudi Arabia (KSA) (Fig. 1 ).
Fig. 1

Country-specific estimates of COVID-19 cases per million inhabitants (From https://www.worldometers.info/coronavirus/).

Country-specific estimates of COVID-19 cases per million inhabitants (From https://www.worldometers.info/coronavirus/). The orders of magnitude difference between Italy (2732/MM) and the KSA (168/MM) speak of an enormous difference in the propagation of COVID-19. This gigantic gap is dwarfed by the three order of magnitude difference between the KSA (168/MM) and the Italian epicenter in the province of Bergamo (>3000/MM). When we examined the mortality rates reported by various countries, the mortality again varies greatly. Italy is reporting the highest mortality (13.1% on April 16, 2020), whereas, Iran (6.3%), China (4%), Spain (10.4%), France (11.6%) and Korea (2.1%) described lower mortality rates. At the bottom of the countries with low mortality are Bahrain and Singapore (with 0.3–0.4% mortality). Are there plausible explanations for the great variability in disease prevalence within the different countries? Social habits (greetings customs, ease to touch another person, kissing etc.) could possibly play a role, as could a greater susceptibility of the population, the presence of “super-spreaders” [4] or a delayed implementation of measures intended to stop the spread of infectious disease such as social distancing and closure of public areas. One study indicated that variation in prevalence could be due to differences in transmission and migration rates [3]. What enabled China to contain the spread of the epidemic was most certainly the coordinated effort of the central government to shut down Wuhan on January 23rd, followed on January 24th by the shutdown of another 15 cities: since then the number of new cases began to go down. This extremely successful endeavor is the result of draconian measures implemented with military discipline, and thus this measure maybe difficult to implement in western countries. Are there plausible explanations for the great variability in mortality rate? There was a variation in the risk of death in a study from China. -The estimates of the risk for death was 12% in the epicenter of Wuhan and 1% in other, more mildly affected areas [5]. A higher average age of the population, (particularly in Italy with a median age of (47.4 years), accompanying higher percentage of comorbidities, most likely play a significant role in death rates. In one study, older age and higher Sequential Organ Failure Assessment (SOFA) score were associated with increased mortality [6]. Sadly, in certain instances, it appears that the underlying cause of dramatically higher mortality, to this date, was a drastic decrease in availability of critical resources. This decrease in resources leads to a functional collapse of the healthcare system and an overwhelmingly and unmanageable surge of people needing assistance in the intensive care units. In the absence of a single plausible explanation for the existence of such dramatic disparities, we feel that home quarantine and isolation of the vulnerable populations (such as the elderly and the frail) along with the draconian measures being implemented in many countries are justified in order to successfully contain and eventually overcome the current pandemic due to COVID-19.

Funding source

None.

Declaration of competing interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
  6 in total

1.  Potential impact of seasonal forcing on a SARS-CoV-2 pandemic.

Authors:  Richard A Neher; Robert Dyrdak; Valentin Druelle; Emma B Hodcroft; Jan Albert
Journal:  Swiss Med Wkly       Date:  2020-03-16       Impact factor: 2.193

2.  Genomic Diversity of Severe Acute Respiratory Syndrome-Coronavirus 2 in Patients With Coronavirus Disease 2019.

Authors:  Zijie Shen; Yan Xiao; Lu Kang; Wentai Ma; Leisheng Shi; Li Zhang; Zhuo Zhou; Jing Yang; Jiaxin Zhong; Donghong Yang; Li Guo; Guoliang Zhang; Hongru Li; Yu Xu; Mingwei Chen; Zhancheng Gao; Jianwei Wang; Lili Ren; Mingkun Li
Journal:  Clin Infect Dis       Date:  2020-07-28       Impact factor: 9.079

3.  Super-spreading events and contribution to transmission of MERS, SARS, and SARS-CoV-2 (COVID-19).

Authors:  J A Al-Tawfiq; A J Rodriguez-Morales
Journal:  J Hosp Infect       Date:  2020-04-08       Impact factor: 3.926

4.  Estimating Risk for Death from Coronavirus Disease, China, January-February 2020.

Authors:  Kenji Mizumoto; Gerardo Chowell
Journal:  Emerg Infect Dis       Date:  2020-06-17       Impact factor: 6.883

5.  Phylogenetic network analysis of SARS-CoV-2 genomes.

Authors:  Peter Forster; Lucy Forster; Colin Renfrew; Michael Forster
Journal:  Proc Natl Acad Sci U S A       Date:  2020-04-08       Impact factor: 11.205

6.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.

Authors:  Fei Zhou; Ting Yu; Ronghui Du; Guohui Fan; Ying Liu; Zhibo Liu; Jie Xiang; Yeming Wang; Bin Song; Xiaoying Gu; Lulu Guan; Yuan Wei; Hui Li; Xudong Wu; Jiuyang Xu; Shengjin Tu; Yi Zhang; Hua Chen; Bin Cao
Journal:  Lancet       Date:  2020-03-11       Impact factor: 79.321

  6 in total
  23 in total

1.  Assessment of Risk Factors Associated with COVID-19 Illness Outcomes in a Tertiary Hospital in Saudi Arabia.

Authors:  Mohammad Aljabr; Areej Aldossary; Kanan Alkanani; Turky Al Zahrani; Sofian Al Mulhim; Hatim Kheir; Assim AlAbdulkader; Hayat Mushcab; Yaser Alreshidi; Nouf Albalawi; Wedyan Alabdullatif; Abrar Almarzooq; Saeed Qahtani; Jaffar A Al-Tawfiq
Journal:  Int J Gen Med       Date:  2022-06-27

Review 2.  Characterization of SARS-CoV-2 different variants and related morbidity and mortality: a systematic review.

Authors:  SeyedAhmad SeyedAlinaghi; Pegah Mirzapour; Omid Dadras; Zahra Pashaei; Amirali Karimi; Mehrzad MohsseniPour; Mahdi Soleymanzadeh; Alireza Barzegary; Amir Masoud Afsahi; Farzin Vahedi; Ahmadreza Shamsabadi; Farzane Behnezhad; Solmaz Saeidi; Esmaeil Mehraeen
Journal:  Eur J Med Res       Date:  2021-06-08       Impact factor: 2.175

3.  A Case Series of Severe Hospitalized COVID-19 Patients Treated with Tocilizumab and Glucocorticoids: A Report from Saudi Arabian Hospital.

Authors:  Salma AlBahrani; Jaffar A Al-Tawfiq; Abdulaziz R Alshaer; Amal Shilash; Khalid Alswefy; Razan Salamah Al-Zayer; Amr Mohamed Abouelela
Journal:  J Epidemiol Glob Health       Date:  2021-01-22

4.  Predictors of COVID-19 severity: a systematic review and meta-analysis.

Authors:  Mudatsir Mudatsir; Jonny Karunia Fajar; Laksmi Wulandari; Gatot Soegiarto; Muhammad Ilmawan; Yeni Purnamasari; Bagus Aulia Mahdi; Galih Dwi Jayanto; Suhendra Suhendra; Yennie Ayu Setianingsih; Romi Hamdani; Daniel Alexander Suseno; Kartika Agustina; Hamdan Yuwafi Naim; Muchamad Muchlas; Hamid Hunaif Dhofi Alluza; Nikma Alfi Rosida; Mayasari Mayasari; Mustofa Mustofa; Adam Hartono; Richi Aditya; Firman Prastiwi; Fransiskus Xaverius Meku; Monika Sitio; Abdullah Azmy; Anita Surya Santoso; Radhitio Adi Nugroho; Camoya Gersom; Ali A Rabaan; Sri Masyeni; Firzan Nainu; Abram L Wagner; Kuldeep Dhama; Harapan Harapan
Journal:  F1000Res       Date:  2020-09-09

5.  Association of clade-G SARS-CoV-2 viruses and age with increased mortality rates across 57 countries and India.

Authors:  Bhaswati Pandit; Samsiddhi Bhattacharjee; Bornali Bhattacharjee
Journal:  Infect Genet Evol       Date:  2021-01-27       Impact factor: 3.342

6.  Clinical and Laboratory Profile of Hospitalized Symptomatic COVID-19 Patients: Case Series Study From the First COVID-19 Center in the UAE.

Authors:  Suad Hannawi; Haifa Hannawi; Kashif Bin Naeem; Noha Mousaad Elemam; Mahmood Y Hachim; Ibrahim Y Hachim; Abdulla Salah Darwish; Issa Al Salmi
Journal:  Front Cell Infect Microbiol       Date:  2021-02-26       Impact factor: 5.293

Review 7.  Immunothrombosis in COVID-19: Implications of Neutrophil Extracellular Traps.

Authors:  Brandon Bautista-Becerril; Rebeca Campi-Caballero; Samuel Sevilla-Fuentes; Laura M Hernández-Regino; Alejandro Hanono; Al Flores-Bustamante; Julieta González-Flores; Carlos A García-Ávila; Arnoldo Aquino-Gálvez; Manuel Castillejos-López; Armida Juárez-Cisneros; Angel Camarena
Journal:  Biomolecules       Date:  2021-05-06

8.  Cross-National Variations in COVID-19 Mortality: The Role of Diet, Obesity and Depression.

Authors:  Ravi Philip Rajkumar
Journal:  Diseases       Date:  2021-05-06

9.  Incidence of COVID-19 among returning travelers in quarantine facilities: A longitudinal study and lessons learned.

Authors:  Jaffar A Al-Tawfiq; Amar Sattar; Husain Al-Khadra; Saeed Al-Qahtani; Mobarak Al-Mulhim; Omar Al-Omoush; Hatim O Kheir
Journal:  Travel Med Infect Dis       Date:  2020-10-10       Impact factor: 6.211

10.  Chest CT in COVID-19: What the Radiologist Needs to Know.

Authors:  Thomas C Kwee; Robert M Kwee
Journal:  Radiographics       Date:  2020-10-23       Impact factor: 5.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.